Doximity is trading 4.35% down now at $20.69, with no company-specific explanation for the decline found before publication.
- The company is scheduled to release fiscal first-quarter results after market close on August 6, 2026, creating a near-term earnings catalyst.
- Broader markets are only modestly mixed, so they do not clearly explain this move.